Progyny, Inc. (PGNY)
| Market Cap | 1.79B |
| Revenue (ttm) | 1.14B |
| Net Income (ttm) | 57.27M |
| Shares Out | 85.15M |
| EPS (ttm) | 0.60 |
| PE Ratio | 35.03 |
| Forward PE | 13.13 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,708,027 |
| Open | 20.71 |
| Previous Close | 20.62 |
| Day's Range | 20.40 - 21.07 |
| 52-Week Range | 13.39 - 42.08 |
| Beta | 1.31 |
| Analysts | Buy |
| Price Target | 19.17 (-8.71%) |
| Earnings Date | Feb 25, 2025 |
About PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various servic... [Read more]
Financial Performance
In 2023, Progyny's revenue was $1.09 billion, an increase of 38.34% compared to the previous year's $786.91 million. Earnings were $62.04 million, an increase of 104.35%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for PGNY stock is "Buy." The 12-month stock price forecast is $19.17, which is a decrease of -8.71% from the latest price.
News
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women's health benefits solution, today announced the appointment of 30-year h...
Securities Fraud Investigation Into Progyny, Inc. (PGNY) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Progyny, Inc. (“Progyny” ...
Progyny, Inc. (PGNY) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) investors concerning the Company's poss...
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
BLOOMFIELD, Conn. , Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasda...
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduc...
The Bottom Fishing Club: Progyny Reverses On Heavy Insider Buying
Progyny shares have plummeted nearly 80% from 2021's peak, but management optimism and insider buying in December signal a potential turnaround during 2025. PGNY's valuation is deeply discounted, with...
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath. According to a CNBC analysis of 39 public digital health com...
PGNY Stockholders: Robbins LLP is Investigating the Officers and Directors of Progyny, Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
SAN DIEGO , Dec. 18, 2024 /PRNewswire/ -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated sec...
Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders
SAN DIEGO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclo...
Four hidden gems in the stock market from a five-star fund manager
Investors might be well served by expanding beyond the S&P 500.
Robbins LLP Informs Progyny, Inc. Stockholders that it is Investigating the Officers and Directors of PGNY to Determine if They Breached Fiduciary Duties Owed to Shareholders
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated ...
Progyny: Rating Downgrade On Uncertain Growth Outlook
I recommend downgrading Progyny from buy to hold due to a loss of confidence in its growth outlook and increased uncertainty. PGNY's Q3 2024 results were disappointing, with revenue and margins fallin...
Progyny: After A Terrible Year, I'm Out (Rating Downgrade)
I initially rated Progyny a "Buy" in late 2022, but 2024 has been disastrous, with a 60% stock drop and loss of Amazon as a client. Q3 2024 financials show minimal revenue growth, declining margins, a...
Progyny, Inc. to Present at Jefferies London Healthcare Conference
NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny'...
These Analysts Slash Their Forecasts On Progyny Following Q3 Results
Progyny, Inc. PGNY reported worse-than-expected third-quarter sales results and issued FY24 revenue guidance below estimates.
Progyny, Inc. (PGNY) Q3 2024 Earnings Call Transcript
Progyny, Inc (NASDAQ:PGNY) Q3 2024 Earnings Conference Call November 12, 2024 4:45 PM ET Company Participants James Hart - Investor Relations Peter Anevski - CEO Michael Sturmer - President Mark Livi...
Progyny, Inc. Announces Third Quarter 2024 Results
Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest Ser...
Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman
SAN FRANCISCO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Fertility benefits provider Progyny, Inc. (NASDAQ: PGNY) is under intense scrutiny following the unexpected announcement of a major client's departure.
Progyny, Inc. Announces Details for Its Third Quarter 2024 Results Report
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the q...
Progyny (PGNY) Crashes After Losing Significant Client - Hagens Berman
PGNY Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCICSO, CA / ACCESSWIRE / October 16, 2024 / Hagens Berman urges Progyny, Inc. (NASDAQ:PGNY) investors who suffered substantial lo...
Progyny: Poor Year Raises Concerns For Future (Downgrade)
Progyny has had a rough start to the year, with the share price declining by double digits in response to both Q1'24 and Q2'24. In September, they filed an 8-K informing investors that they lost their...
Progyny, Inc. (PGNY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / October 2, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. ("Progyny" or "the Company") (NASDAQ:PG...
Bronstein, Gewirtz & Grossman, LLC Encourages Progyny, Inc. (PGNY) Shareholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESSWIRE / October 1, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. ("Progyny" or "the Company") (NASDAQ:PG...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Progyny, Inc. (PGNY) And Encourages Shareholders to Connect
NEW YORK CITY, NY / ACCESSWIRE / September 30, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. ("Progyny" or "the Company") (NASDAQ...
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Progyny, Inc. (PGNY) And Encourages Shareholders to Reach Out
NEW YORK CITY, NY / ACCESSWIRE / September 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. ("Progyny" or "the Company") (NASDAQ...